sch 16134 has been researched along with Anxiety Disorders in 1 studies
quazepam: structure given in first source
Anxiety Disorders: Persistent and disabling ANXIETY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The mean number of insomnia complaints was significantly (p < ." | 2.67 | Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients. ( Mendels, J, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mendels, J | 1 |
1 trial available for sch 16134 and Anxiety Disorders
| Article | Year |
|---|---|
Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients.
Topics: Adolescent; Adult; Ambulatory Care; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; Be | 1994 |